Search research articles
Contact Us
Filters
Showing results (131-140 of 173) with videos related to
Page
of 18
Sort By:
Journal of Clinical Medicine
|
April 3, 2021
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration
Allen C Ho, Jeffrey S Heier, Nancy M Holekamp, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
Rachel E Sanborn, Helen J Ross, Sandra Aung, et al.
JTO Clinical and Research Reports
|
February 8, 2024
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors
Kathryn E Beckermann, Christine M Bestvina, Badi El Osta, et al.
British Journal of Cancer
|
December 4, 2025
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
Noboru Yamamoto, Dong Yan, Vinod Ganju, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer
Martin J Edelman, Ming T Tan, Mary J Fidler, et al.
Journal of Radioanalytical and Nuclear Chemistry
|
June 26, 2023
Separation of protactinium from uranium-niobium alloys for <sup>231</sup>Pa-<sup>235</sup>U radiochronometry in nuclear forensic investigations
Christine Yifeng Chen, Matthew A Higginson, Theresa M Kayzar-Boggs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 10, 2026
Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L)
Suresh S Ramalingam, Vamsidhar Velcheti, Mehmet Altan, et al.
The Oncologist
|
July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors
Khanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
Science Translational Medicine
|
April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205
Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
Makoto Nishio, Fabrice Barlesi, Howard West, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 173) with videos related to
Sort By:
Page
of 18
Journal of Clinical Medicine
|
April 3, 2021
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular Degeneration
Allen C Ho, Jeffrey S Heier, Nancy M Holekamp, et al.
Journal for Immunotherapy of Cancer
|
December 21, 2017
A pilot study of an autologous tumor-derived autophagosome vaccine with docetaxel in patients with stage IV non-small cell lung cancer
Rachel E Sanborn, Helen J Ross, Sandra Aung, et al.
JTO Clinical and Research Reports
|
February 8, 2024
A Phase 1/2 Study to Evaluate the Safety and Activity of Nivolumab in Combination With Vorolanib, a Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitor, in Patients With Refractory Thoracic Tumors
Kathryn E Beckermann, Christine M Bestvina, Badi El Osta, et al.
British Journal of Cancer
|
December 4, 2025
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
Noboru Yamamoto, Dong Yan, Vinod Ganju, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 3, 2014
Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer
Martin J Edelman, Ming T Tan, Mary J Fidler, et al.
Journal of Radioanalytical and Nuclear Chemistry
|
June 26, 2023
Separation of protactinium from uranium-niobium alloys for <sup>231</sup>Pa-<sup>235</sup>U radiochronometry in nuclear forensic investigations
Christine Yifeng Chen, Matthew A Higginson, Theresa M Kayzar-Boggs, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 10, 2026
Phase 3 Study of Niraparib-Plus-Pembrolizumab as Maintenance Therapy for Advanced/Metastatic Non-Small Cell Lung Cancer (ZEAL-1L)
Suresh S Ramalingam, Vamsidhar Velcheti, Mehmet Altan, et al.
The Oncologist
|
July 21, 2021
First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors
Khanh T Do, Laura Quan Man Chow, Karen Reckamp, et al.
Science Translational Medicine
|
April 18, 2014
Induction of antigen-specific immunity with a vaccine targeting NY-ESO-1 to the dendritic cell receptor DEC-205
Madhav V Dhodapkar, Mario Sznol, Biwei Zhao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 17, 2020
Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial
Makoto Nishio, Fabrice Barlesi, Howard West, et al.
Page
of 18